ESH-iCMLf 22nd Annual John Goldman E-Conference on
Chronic Myeloid Leukemia: Biology and Therapy
Chairs: Jorge Cortes, Tim P. Hughes, Daniela S. Krause
Co-organizers: Ravi Bhatia, Tim Brümmendorf, Mhairi Copland, Michael Deininger, Olivier Hantschel, François-Xavier Mahon, Danilo Perrotti, Jerry Radich, Delphine Réa
Advisory Committee: Jane Apperley, Susan Branford, Carlo Gambacorti-Passerini, François Guilhot, Rüdiger Hehlmann, Pierre Laneuville, Giuseppe Saglio, Charles Schiffer, Simona Soverini, Peter Valent, Rick Van Etten

ESH-iCMLf 22nd Annual John Goldman E-Conference on
Chronic Myeloid Leukemia: Biology and Therapy
Information
ABOUT THE CONFERENCE:
Speakers at this meeting will present the newest and often unpublished data relating to the (1) Biology of CML including the origin of BCR-ABL1, signal transduction, basis of disease progression, action of tyrosine kinase inhibitors and mechanisms underlying resistance to TKI, and (2) aspects of treatment including prediction and definition of responses, drugs used in combination, modern diagnostics and molecular monitoring, targeting residual stem cells, approaches to cure and treatment free remission.
SCIENTIFIC TOPICS:
• Stem Cells and the microenvironment
• Molecular biology and new targets
• Proteomics and Secretomics
• Artificial Intelligence and Machine Learning
• Mechanisms of resistance and disease progression
• Biomarkers
• Immunology and Inflammation
• Therapeutic interventions
• Immunotherapy
• Treatment free remission
• Safety and patient reported outcomes
• Clinical trial design
• The new ELN recommendations
• New drugs in development
Program
Read the final program!


